SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-286962
Filing Date
2020-11-05
Accepted
2020-11-05 16:58:32
Documents
14
Period of Report
2020-10-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d89627d8ka.htm   iXBRL 8-K/A 32587
2 EX-99.1 d89627dex991.htm EX-99.1 306284
3 EX-99.2 d89627dex992.htm EX-99.2 178056
  Complete submission text file 0001193125-20-286962.txt   709209

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kdny-20201005.xsd EX-101.SCH 2727
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20201005_lab.xml EX-101.LAB 19591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20201005_pre.xml EX-101.PRE 12274
7 EXTRACTED XBRL INSTANCE DOCUMENT d89627d8ka_htm.xml XML 6229
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37345 | Film No.: 201291361
SIC: 2834 Pharmaceutical Preparations